Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective. [electronic resource]
- Cardiovascular drugs and therapy Jun 2010
- 207-16 p. digital
Publication Type: Journal Article
1573-7241
10.1007/s10557-010-6245-9 doi
Aspirin--adverse effects Clopidogrel Hemorrhage--chemically induced Humans Platelet Aggregation Inhibitors--adverse effects Randomized Controlled Trials as Topic--methods Retrospective Studies Risk Thrombosis--prevention & control Ticlopidine--adverse effects Time Factors Vascular Diseases--drug therapy